Coordinatore | SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST
Organization address
address: BEECH HILL ROAD 8 contact info |
Nazionalità Coordinatore | United Kingdom [UK] |
Totale costo | 3˙235˙968 € |
EC contributo | 3˙235˙968 € |
Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
Code Call | FP7-PEOPLE-ITN-2008 |
Funding Scheme | MC-ITN |
Anno di inizio | 2010 |
Periodo (anno-mese-giorno) | 2010-01-01 - 2014-12-31 |
# | ||||
---|---|---|---|---|
1 |
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST
Organization address
address: BEECH HILL ROAD 8 contact info |
UK (SHEFFIELD) | coordinator | 438˙214.00 |
2 |
UNIVERSITAIR ZIEKENHUIS ANTWERPEN
Organization address
address: WILRIJKSTRAAT 10 contact info |
BE (EDEGEM) | participant | 445˙989.00 |
3 |
UNIVERSITEIT MAASTRICHT
Organization address
address: Minderbroedersberg 4-6 contact info |
NL (MAASTRICHT) | participant | 429˙483.00 |
4 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | participant | 425˙908.00 |
5 |
Astellas Pharma Europe B.V
Organization address
address: Elisabethhof 1 contact info |
NL (Leiderdorp) | participant | 239˙394.00 |
6 |
NORTH BRISTOL NATIONAL HEALTH SERVICE TRUST
Organization address
address: BECKSPOOL ROAD FRENCHAY HOSPITAL . contact info |
UK (BRISTOL) | participant | 219˙107.00 |
7 |
Plethora Solutions Limited
Organization address
address: High Holburn 233 4th floor contact info |
UK (London) | participant | 219˙107.00 |
8 |
SHEFFIELD HALLAM UNIVERSITY
Organization address
address: HOWARD STREET contact info |
UK (SHEFFIELD) | participant | 218˙991.00 |
9 |
KATHOLIEKE UNIVERSITEIT LEUVEN
Organization address
address: Oude Markt 13 contact info |
BE (LEUVEN) | participant | 213˙356.00 |
10 |
THE UNIVERSITY OF SHEFFIELD
Organization address
address: FIRTH COURT WESTERN BANK contact info |
UK (SHEFFIELD) | participant | 198˙431.00 |
11 |
WARSZAWSKI UNIWERSYTET MEDYCZNY
Organization address
address: UL. ZWIRKI I WIGURY 61 contact info |
PL (WARSZAWA) | participant | 187˙988.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Urinary Incontinence (UI) affects around 10% of the population (more than 70 Million people in the EU) and unfortunately - due to the aging population - is an increasing cause of impaired quality of life. The most common cause of UI is called the Overactive bladder syndrome (OABS) of which the underlying complex bio-molecular mechanisms are poorly understood. Many distinct tissues (nervous system, urothelium, interstitial cells, smooth muscle cells) contribute to OABS but their specific roles remain unknown. As a result, no effective non-invasive therapy without side effects is available or can be developed without a profound integration of multiple scientific disciplines. The TRUST ITN proposes an interdisciplinary research training network of 8 European university institutes and 3 enterprises, with a wide variety of complementary expertise in UI and OABS. The network covers all required disciplines from anatomy, urology, neuroscience, pathology, pharmacology, biomedical engineering, clinical science, bioinformatics to diagnostic- and drug development, that must be applied on cellular-, organ- and whole body levels. Currently most researchers are not trained to deal with such a great variety of disciplines, and are thus insufficiently prepared to cope with the modern and increasingly urgent challenges of urology research. In the TRUST project 10 early stage researchers and 5 experienced researchers will receive training from different leading European research institutes on multiple complementary disciplines that will empower them to explore the and unravel the mechanisms underlying OABS and to develop novel diagnostic, prevention and treatment strategies. Moreover, the integrated research training programme will transfer practical skills, knowledge and experiences to stimulate successful medical (commercial) exploitation of these results. Finally, the unique multidisciplinary scientific profiles of the researchers will open-up promising career perspectives.'